| Value | ₹57.92 Cr |
|---|
NSE filing, NSE: AMRUTANJAN. Summary written from the filing by ALFA Finder's alert engine.
Amrutanjan Health Care Ltd: key numbers
- Share price
- ₹496.65
- Market cap
- ₹1,436 Cr
- Revenue (annual)
- ₹502.6 Cr
- Net profit (annual)
- ₹57.92 Cr
- P/E (TTM)
- 26.6×Sector 45.9×
- Promoter holding
- 46.52%+0.00% QoQ
- FII holding
- 3.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amrutanjan Health Care Ltd
All →Amrutanjan Health Care Board Meeting Date
Amrutanjan Health Care scheduled its board meeting for 3 Nov 2026 to consider Q2/H1 results and 1st interim dividend. No financial figures or dividend amount are stated in this advance intimation.
Amrutanjan Health Care Other Announcement
Amrutanjan Health Care received a voluntary CRISIL ESG rating of 'Adequate' (score 60). No capital or operational impact arises from this rating.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend of Rs. 2.90 per share.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend.
- Value
- ₹0.06 Cr
Amrutanjan Health Care Business Update
Amrutanjan Health Care Limited submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26. This disclosure forms part of the company's Annual Report requirements.
Other financial results announcements
All →Sai Parenterals Q2 FY27 Results: Net Profit ₹10.5 Cr, Up 66.7% YoY
Sai Parenterals Ltd reported revenue from operations of ₹194.9 Cr (+264.3% YoY) and net profit of ₹10.5 Cr (+66.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹10.5 Cr · +66.7% YoY
Confidence Futuristic Energetech Q2 FY27 Results: Net Profit ₹1.2 Cr, Up 500.0% YoY
Confidence Futuristic Energetech Ltd reported revenue from operations of ₹41.7 Cr (+66.8% YoY) and net profit of ₹1.2 Cr (+500.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.2 Cr · +500.0% YoY
Priority Jewels Q2 FY27 Results: Net Profit ₹6.5 Cr, Up 22.6% YoY
Priority Jewels Ltd reported revenue from operations of ₹183.5 Cr (+16.5% YoY) and net profit of ₹6.5 Cr (+22.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹6.5 Cr · +22.6% YoY
Integra Essentia Q2 FY27 Results: Net Profit ₹0 Cr
Integra Essentia Ltd reported revenue from operations of ₹142 Cr (+17.6% YoY) and net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Mercury Ev-Tech Q2 FY27 Results: Net Profit ₹1.2 Cr, Down 33.3% YoY
Mercury Ev-Tech Ltd reported revenue from operations of ₹30.1 Cr (-11.5% YoY) and net profit of ₹1.2 Cr (-33.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.2 Cr · -33.3% YoY
Jay Jalaram Technologies H1 FY27 Results: Net Profit ₹9.3 Cr, Up 78.8% YoY
Jay Jalaram Technologies Ltd reported revenue from operations of ₹655.8 Cr (+83.7% YoY) and net profit of ₹9.3 Cr (+78.8% YoY) for H1 FY27.
- Key figure
- Net profit ₹9.3 Cr · +78.8% YoY